MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Sells 10,552 Shares of Colgate-Palmolive (NYSE:CL)

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH lowered its holdings in shares of Colgate-Palmolive (NYSE:CL) by 43.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,523 shares of the company’s stock after selling 10,552 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s holdings in Colgate-Palmolive were worth $1,228,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. XTX Topco Ltd bought a new position in Colgate-Palmolive during the 2nd quarter valued at approximately $423,000. Evergreen Capital Management LLC grew its stake in shares of Colgate-Palmolive by 4.2% in the second quarter. Evergreen Capital Management LLC now owns 3,490 shares of the company’s stock worth $339,000 after acquiring an additional 141 shares during the last quarter. AlTi Global Inc. increased its holdings in shares of Colgate-Palmolive by 2.9% during the second quarter. AlTi Global Inc. now owns 4,281 shares of the company’s stock valued at $415,000 after acquiring an additional 119 shares in the last quarter. AQR Capital Management LLC raised its position in shares of Colgate-Palmolive by 58.6% in the 2nd quarter. AQR Capital Management LLC now owns 2,416,943 shares of the company’s stock worth $234,540,000 after purchasing an additional 892,706 shares during the last quarter. Finally, APG Asset Management N.V. boosted its stake in Colgate-Palmolive by 64.3% in the 2nd quarter. APG Asset Management N.V. now owns 1,251,422 shares of the company’s stock worth $113,308,000 after purchasing an additional 489,977 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of CL opened at $87.98 on Friday. The business has a 50-day simple moving average of $92.00 and a two-hundred day simple moving average of $97.58. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 52 week low of $80.03 and a 52 week high of $109.30. The stock has a market cap of $71.88 billion, a price-to-earnings ratio of 25.21, a PEG ratio of 3.62 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.27%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 57.31%.

Analyst Upgrades and Downgrades

CL has been the subject of several recent analyst reports. Barclays decreased their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. UBS Group cut their target price on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Finally, Stifel Nicolaus reduced their price objective on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $101.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.